Depression, Anxiety, Dizziness, Pain, Signs and Symptoms
Conditions
Keywords
biofield therapy, ethnic differences, Okada Purifying Therapy, effectiveness, safety
Brief summary
Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.
Detailed description
Participants aged 16 or older from 14 different countries (Japan, USA, Argentina, Brazil, Chile, Mexico, Peru, Taiwan, Thai, South Korea, Belgium, France, Portugal, and Spain) received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners in their country of residence. Before and after the intervention, they reported each severity level of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the improvement/exacerbation rate of a single session of biofield therapy between the countries, and examined the adjusted odds ratio of the variables associated with the changes in each category of symptoms in a real-world setting.
Interventions
The practitioner raises his/her hand forward towards the recipient with the palm directed toward the recipient. The practitioner uses his/her hands alternately during the administration of Okada Purifying Therapy. The distance between the palm and the body is usually 1-2 feet, with each session typically lasting 30 to 60 minutes.
Sponsors
MOA Health Science Foundation
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
1. Individuals who agreed to receive a single session of biofield therapy for 30 minutes or longer from the volunteer investigators. 2. Individuals who were able to self-evaluate the change of their symptoms. 3. Individuals who were competent to answer the questionnaires. 4. Individuals who were aged 16 or older.
Exclusion criteria
* no specific
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| improvement/exacerbation rate of symptoms after a single session of biofield therapy | Up to one year after all the data were collected. | The Mann-Whitney test was conducted to compare the improvement/exacerbation rates between countries. |
| adjusted odds ratio of the factors associated with the changes in symptoms | Up to one year after all the data were collected. | Logistic regression analyses |
Outcome results
None listed